Visual evoked potentials (VEPs) in Parkinson's disease: correlation of pattern VEPs abnormality with dementia [0.03%]
帕金森病的视觉诱发电位（VEP）与痴呆相关的模式异常_VEPA
B Okuda,H Tachibana,K Kawabata et al.
B Okuda et al.
There has been some debate about abnormalities in visual evoked potentials (VEP) in Parkinson's disease (PD). To elucidate the mechanism underlying abnormal VEPs, we investigated the relationship between pattern-reversal VEPs elicited by la...
A M Kazee,C Cox,E K Richfield
A M Kazee
Clinical and pathological overlap between Alzheimer disease (AD) and Parkinson's disease (PD) has been well described; however, the mechanisms of overlap between these two disorders remain unknown. We retrospectively examined clinical and n...
Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease [0.03%]
急性期反应物蛋白α1抗胆碱酶在可能患有阿尔茨海默病的患者脑脊液和血液中的增多现象
F Licastro,L Parnetti,M C Morini et al.
F Licastro et al.
Levels of alpha 1-antichymotrypsin (alpha 1-ACT) in cerebrospinal fluid (CSF) and serum from patients with probable Alzheimer disease (AD) of both early (e-AD) and late (l-AD) onset assessed by a competitive enzyme-linked immunosorbent assa...
The screening of mild dementia with a shortened Spanish version of the "Informant Questionnaire on Cognitive Decline in the Elderly" [0.03%]
简短的西班牙版《老年人认知衰退同伙筛查量表》在轻度痴呆筛选中的应用
J M Morales,J I Gonzalez-Montalvo,F Bermejo et al.
J M Morales et al.
Most of the present screening tests for the detection of dementia fail with mild dementia. Jorm et al. recently presented the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), a simple instrument with good diagnostic val...
Relationship between level of insight and severity of dementia in Alzheimer disease. CERAD Clinical Investigators. Consortium to Establish a Registry for Alzheimer's Disease [0.03%]
阿尔茨海默病患者幻觉妄想与痴呆严重程度的关系（CERAD临床研究员）
K D McDaniel,S D Edland,A Heyman
K D McDaniel
Although the cognitive and psychiatric symptoms associated with Alzheimer disease have received increasing attention over the past decade, the study of insight in this illness has been relatively neglected. This paper reports on the relatio...
K Herholz
K Herholz
Positron emission tomography (PET) with 18F-2-fluoro-2-deoxy-D-glucose (FDG) demonstrates a typical pattern of impairment of regional metabolic rates of glucose (rCMRGlu) in most patients with a clinical diagnosis of probable Alzheimer's di...
S Kotler-Cope,C J Camp
S Kotler-Cope
This study evaluated Alzheimer disease (AD) patients' awareness of impairment in several domains, including cognitive, psychiatric, and behavioral functioning. Ratings made by 13 patients with moderate to moderately severe probable AD were ...
R S Frackowiak
R S Frackowiak
Characterisation of an antibody relevant to the neuropathology of Alzheimer disease [0.03%]
与阿尔茨海默病神经病理相关的抗体的特征研究
R Jakes,C R Harrington,M G Spillantini et al.
R Jakes et al.
The specificity of BR88, a polyclonal antibody we raised against amino acids 1-12 of beta/A4 (beta-amyloid protein), has been reexamined in view of a claim made that it cross-reacts with tau-protein, probably the sole component of the paire...
M Brilliant,L Hughes,D Anderson et al.
M Brilliant et al.
Magnetic resonance head scans of 94 patients with probable Alzheimer disease (AD) and 45 patients with possible AD were examined prospectively to determine the prevalence and significance of rarefied cerebral white matter (leukoaraiosis) in...